LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30146% above fair value

$14.15−0.22 (-1.53%)

Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –

LifeStance Health r&d expenses

Research and development expenses are spending on new products and technology.

LifeStance Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in LifeStance Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFST.

Revenue growth22.6% · median 15.9%

Operating margin6.2% · median 2.1%

Net margin4.3% · median 1.4%

Advertisement
300 × 250

See a number that looks wrong?